Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Champions Oncology, Inc. CSBR

Set alert

Price alert · CSBR

All alert types
4.81 USD 0.00 0.00%

At close · Oct 30

4.81 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
4.80 × 2
Ask
4.93 × 2
4.76 Day range 4.95
4.69 52-week range 7.80
YTD
-30.39%
1 year
-29.37%
Open
4.86
Prev close
4.81
Mkt cap
66.95M
Vol
8.44K
Avg vol
10.78K
EPS
-0.07
P/E
0.00
Div yield
0.00%
More statistics
Low
4.76
High
4.95
Forward P/E
42.68
Beta
0.49
Short ratio
20.86
Inst. own
49.09%
Dividend
0.00
Ex-div date
50-d avg
4.71
200-d avg
4.79
1y target
8.00

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for CSBR has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-0.28 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -74.5×
FY 2017: -4.1×FY 2018: -33.3×FY 2019: 804×FY 2020: -42.9×FY 2021: 389×FY 2022: 185×FY 2023: -12.5×FY 2024: -9.0×FY 2025: 21.0×FY 2026: -74.5×
FY 2017 5y median -9.0× FY 2026
P/S 1.4×
FY 2017: 1.8×FY 2018: 2.4×FY 2019: 3.8×FY 2020: 2.8×FY 2021: 3.4×FY 2022: 2.1×FY 2023: 1.2×FY 2024: 1.3×FY 2025: 1.7×FY 2026: 1.4×
FY 2017 5y median 1.4× FY 2026
P/B 20.9×
FY 2017: 70.2×FY 2018: 15883×FY 2019: 46.0×FY 2020: 17.9×FY 2021: 19.0×FY 2022: 11.1×FY 2023: 14.2×FY 2024: -34.5×FY 2025: 25.9×FY 2026: 20.9×
FY 2017 5y median 14.2× FY 2026
P/FCF -16.4×
FY 2017: -7.8×FY 2018: -19.4×FY 2019: 100×FY 2020: 133×FY 2021: -28.4×FY 2022: 24.6×FY 2023: 60.8×FY 2024: -9.4×FY 2025: 14.0×FY 2026: -16.4×
FY 2017 5y median 14.0× FY 2026
EV/EBITDA 183×
FY 2017: -3.7×FY 2018: -47.1×FY 2019: 114×FY 2020: -114×FY 2021: 94.1×FY 2022: 46.1×FY 2023: -21.3×FY 2024: -13.0×FY 2025: 15.0×FY 2026: 183×
FY 2017 5y median 15.0× FY 2026
EV/Sales 1.4×
FY 2017: 1.6×FY 2018: 2.3×FY 2019: 3.7×FY 2020: 2.7×FY 2021: 3.6×FY 2022: 2.1×FY 2023: 1.2×FY 2024: 1.4×FY 2025: 1.7×FY 2026: 1.4×
FY 2017 5y median 1.4× FY 2026
FCF Yield -6.1%
FY 2017: -12.8%FY 2018: -5.2%FY 2019: 1.0%FY 2020: 0.7%FY 2021: -3.5%FY 2022: 4.1%FY 2023: 1.6%FY 2024: -10.6%FY 2025: 7.2%FY 2026: -6.1%
FY 2017 5y median 1.6% FY 2026

Profitability

Gross Margin 48.0%
FY 2017: 37.0%FY 2018: 47.9%FY 2019: 47.3%FY 2020: 47.1%FY 2021: 47.7%FY 2022: 51.9%FY 2023: 45.2%FY 2024: 41.4%FY 2025: 50.1%FY 2026: 48.0%
FY 2017 5y median 48.0% FY 2026
Operating Margin -1.9%
FY 2017: -44.2%FY 2018: -6.7%FY 2019: 1.0%FY 2020: -6.0%FY 2021: 0.9%FY 2022: 1.2%FY 2023: -8.3%FY 2024: -13.8%FY 2025: 8.5%FY 2026: -1.9%
FY 2017 5y median -1.9% FY 2026
Net Margin -2.0%
FY 2017: -44.7%FY 2018: -7.3%FY 2019: 0.5%FY 2020: -6.5%FY 2021: 0.9%FY 2022: 1.1%FY 2023: -9.9%FY 2024: -14.5%FY 2025: 8.3%FY 2026: -2.0%
FY 2017 5y median -2.0% FY 2026
ROE -29.8%
FY 2017: -1721.0%FY 2018: -49200.0%FY 2019: 5.7%FY 2020: -41.0%FY 2021: 4.9%FY 2022: 6.0%FY 2023: -115.1%FY 2024: 382.3%FY 2025: 124.6%FY 2026: -29.8%
FY 2017 5y median 6.0% FY 2026
ROIC -13.3%
FY 2017: -1156.0%FY 2018: -217.7%FY 2019: 4.6%FY 2020: -21.2%FY 2021: 1.8%FY 2022: 3.0%FY 2023: -32.3%FY 2024: -116.2%FY 2025: 48.6%FY 2026: -13.3%
FY 2017 5y median -13.3% FY 2026
ROA -4.4%
FY 2017: -85.9%FY 2018: -18.3%FY 2019: 1.1%FY 2020: -10.1%FY 2021: 1.3%FY 2022: 1.5%FY 2023: -15.5%FY 2024: -27.8%FY 2025: 14.5%FY 2026: -4.4%
FY 2017 5y median -4.4% FY 2026

Growth (YoY)

Revenue 4.4%
FY 2017: 37.8%FY 2018: 31.3%FY 2019: 33.7%FY 2020: 18.7%FY 2021: 27.8%FY 2022: 19.7%FY 2023: 9.7%FY 2024: -6.9%FY 2025: 13.5%FY 2026: 4.4%
FY 2017 FY 2026
Operating Income -123.5%
FY 2017: 34.0%FY 2018: 80.1%FY 2019: 119.9%FY 2020: -811.5%FY 2021: 119.1%FY 2022: 65.8%FY 2023: -832.9%FY 2024: -55.6%FY 2025: 170.0%FY 2026: -123.5%
FY 2017 FY 2026
EPS (diluted) -124.2%
FY 2017: 47.5%FY 2018: 79.4%FY 2019: 107.0%FY 2020: -2078.0%FY 2021: 113.8%FY 2022: 56.0%FY 2023: -1107.8%FY 2024: -38.5%FY 2025: 161.1%FY 2026: -124.2%
FY 2017 FY 2026
Free Cash Flow -172.0%
FY 2017: 46.8%FY 2018: 31.9%FY 2019: 141.9%FY 2020: -33.4%FY 2021: -824.4%FY 2022: 182.9%FY 2023: -73.7%FY 2024: -743.9%FY 2025: 200.3%FY 2026: -172.0%
FY 2017 FY 2026

Financial Health

Current Ratio 1.0×
FY 2017: 0.8×FY 2018: 0.7×FY 2019: 1.0×FY 2020: 1.1×FY 2021: 1.1×FY 2022: 1.1×FY 2023: 0.9×FY 2024: 0.6×FY 2025: 0.9×FY 2026: 1.0×
FY 2017 5y median 0.9× FY 2026
Quick Ratio 1.0×
FY 2017: 0.8×FY 2018: 0.7×FY 2019: 1.0×FY 2020: 1.1×FY 2021: 1.1×FY 2022: 1.1×FY 2023: 0.9×FY 2024: 0.6×FY 2025: 0.9×FY 2026: 1.0×
FY 2017 5y median 0.9× FY 2026
Debt / Equity 1.1×
FY 2017: 0.2×FY 2018: 14.3×FY 2019: 0.0×FY 2020: 0.7×FY 2021: 1.3×FY 2022: 1.0×FY 2023: 1.9×FY 2024: -3.9×FY 2025: 1.6×FY 2026: 1.1×
FY 2017 5y median 1.1× FY 2026
Net Debt / EBITDA -0.8×
FY 2017: 0.5×FY 2018: 0.8×FY 2019: -3.7×FY 2020: 6.0×FY 2021: 3.2×FY 2022: 0.2×FY 2023: 0.5×FY 2024: -0.9×FY 2025: -0.6×FY 2026: -0.8×
FY 2017 5y median -0.6× FY 2026
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-04-30